Want to see IN:NH full AI Analyst Report?
NH Stock Chart & Stats
₹1756.45
₹14.10(1.04%)
At close: 4:00 PM EST
₹1756.45
₹14.10(1.04%)
Day’s Range― - ―
52-Week Range₹1,564.25 - ₹2,094.30
Previous CloseN/A
Volume860.19K
Average Volume (3M)21.88K
Market Cap
₹336.58B
Enterprise Value₹359.27B
Total Cash (Recent Filing)₹25.20B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)41.0
Beta0.99
Next Earnings
Nov 11, 2026EPS Estimate
12.67Next Dividend Ex-DateN/A
Dividend Yield0.27%
Share Statistics
EPS (TTM)40.12
Shares Outstanding204,360,800
10 Day Avg. Volume34,818
30 Day Avg. Volume21,877
Financial Highlights & Ratios
PEG Ratio19.78
Price to Book (P/B)7.32
Price to Sales (P/S)4.21
P/FCF Ratio55.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)52.93
Revenue Forecast (FY)₹110.22B
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthRevenue growth accelerated from 12.1% in FY2025 to 31.8% in FY2026, indicating stronger demand and expanding hospital activity. If sustained, this scale can support broader service capacity and improve the company’s ability to spread fixed costs across patient-care revenue.
Improved ProfitabilityNH moved from a FY2021 loss to consistent profits, with improved profitability supported by expanding gross profit dollars and higher absolute earnings. That progress strengthens internal funding capacity and suggests the operating model has become more resilient than in earlier years.
Stronger Cash GenerationOperating cash flow increased to 16.2B in FY2026 from 9.9B, while free cash flow recovered to 7.5B. Stronger cash conversion gives NH more capacity to fund hospital investment and operations from internally generated resources, supporting financial self-sufficiency.
Bears Say
Higher LeverageTotal debt rose sharply to 58.6B in FY2026 from 24.3B, while equity increased to 45.4B. The resulting leverage step-up raises financial risk, increases obligations that cash flows must support, and reduces flexibility if operating conditions weaken.
Volatile Free Cash FlowFree cash flow swung from 5.6B in FY2023 to slightly positive in FY2024, negative in FY2025, and 7.5B in FY2026. This volatility shows that investment cycles and working-capital movements can materially affect internally available cash and planning visibility.
Margin VolatilityThe summary flags margin volatility year to year despite improved profitability and higher earnings. Uneven margins can make earnings less predictable and complicate reinvestment planning, so sustaining the recent operating improvement remains important for durable financial performance.
Narayana Hrudayalaya Ltd. News
NH FAQ
What was Narayana Hrudayalaya Ltd.’s price range in the past 12 months?
Narayana Hrudayalaya Ltd. lowest stock price was ₹1564.25 and its highest was ₹2094.30 in the past 12 months.
What is Narayana Hrudayalaya Ltd.’s market cap?
Narayana Hrudayalaya Ltd.’s market cap is ₹336.58B.
When is Narayana Hrudayalaya Ltd.’s upcoming earnings report date?
Narayana Hrudayalaya Ltd.’s upcoming earnings report date is Nov 11, 2026 which is in 18 days.
How were Narayana Hrudayalaya Ltd.’s earnings last quarter?
Narayana Hrudayalaya Ltd. released its earnings results on Jul 31, 2026. The company reported ₹10.1 earnings per share for the quarter, missing the consensus estimate of ₹11.947 by -₹1.847.
Is Narayana Hrudayalaya Ltd. overvalued?
According to Wall Street analysts Narayana Hrudayalaya Ltd.’s price is currently Overvalued.
Does Narayana Hrudayalaya Ltd. pay dividends?
Narayana Hrudayalaya Ltd. pays a Annually dividend of ₹4.5 which represents an annual dividend yield of 0.27%. See more information on Narayana Hrudayalaya Ltd. dividends here
What is Narayana Hrudayalaya Ltd.’s EPS estimate?
Narayana Hrudayalaya Ltd.’s EPS estimate is 12.67.
How many shares outstanding does Narayana Hrudayalaya Ltd. have?
Narayana Hrudayalaya Ltd. has 204,360,800 shares outstanding.
What happened to Narayana Hrudayalaya Ltd.’s price movement after its last earnings report?
Narayana Hrudayalaya Ltd. reported an EPS of ₹10.1 in its last earnings report, missing expectations of ₹11.947. Following the earnings report the stock price went down -2.491%.
Which hedge fund is a major shareholder of Narayana Hrudayalaya Ltd.?
Currently, no hedge funds are holding shares in IN:NH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited, established in 2000 and headquartered in Bengaluru, India, operates as a prominent provider of medical and healthcare services. The company oversees and manages a diverse range of healthcare facilities, encompassing hospitals, clinics, health centers, and nursing homes. It delivers specialized care across a comprehensive spectrum of medical disciplines, including cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicine, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. As of June 30, 2022, Narayana Hrudayalaya maintained an extensive network that included 19 owned or operated hospitals, 2 managed hospitals, 4 heart centers, and 18 clinics and information centers throughout India, complemented by an international presence with one hospital in the Cayman Islands. Additionally, the company extends its expertise through healthcare consultancy services, which involve the licensing of its ERP solutions.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―